FOLH1 and renal cell carcinoma: Besides, Watanabe et al. [13] revealed that Prostate-Specific Membrane Antigen (PSMA)-positive tumor vessels in renal cell carcinoma exhibit high angiogenic potential, serving as both therapeutic targets and recurrence predictors of kidney renal clear cell carcinoma.